Ovarian cancer is an abnormal cell growth (tumour ... of homologous recombination and mismatch repair status in tumor tissues, allowing drug efficacy to be predicted.

CK Wang, MD, explains that Black women face higher rates of late-stage breast and ovarian cancer diagnoses, demonstrating the ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

New techniques used to analyze soft tissue in dinosaur fossils may hold the key to new cancer discoveries, according to a ...

Imagine cells navigating through a complex maze, guided by chemical signals and the physical landscape of their environment.

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of ...

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients ...

Progression-free survival (PFS) and second PFS (PFS2) by disease stage in patients (pts) with homologous recombination deficiency (HRD)-positive newly diagnosed advanced ovarian cancer receiving ...

Antitumor therapies have conventionally been evaluated based on their capacity to eliminate malignant cells. However, growing evidence highlights that drugs ...